PainReform Stock Drops after Announcement of Strategic Investment in LayerBio
PainReform stock took a hit after the company shared big news on July 10, 2025. The pharmaceutical firm, listed on Nasdaq as PRFX, revealed a strategic investment of up to $3 million in LayerBio Inc., a business working on eye care solutions. This move gives PainReform a majority stake and a board position, but the stock market responded with an 11% drop in PainReform stock value.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
